Omers Administration Corp Allakos Inc. Transaction History

Omers Administration Corp

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2020 May 15, 2020	SELL	$44.49 - $93.39 $231,348 - $485,628	-5,200 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$66.49 - $137.73 $345,748 - $716,196	5,200 New	5,200 $496,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $73.7M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Omers Administration Corp, based on Form 13F filings with the SEC.

Stay updated on Omers Administration Corp with notifications on news.